However, considering the disease severity associated with synucleinopathies of included patients, it seems unlikely that low-titre weak ANA could account for the disease, as autoantibody concentrations and thereby fluorescent intensity are associated with disease activity in other autoimmune diseases [25]. Here, BTG3 is linked to autoimmune disease.